Dr. Paul M. Bloomston
Claim this profileRegional Cancer Center-Lee Memorial Health System
About Paul M. Bloomston
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Radiation Oncology at the University of Florida College of Medicine – Jacksonville.
- Undertook a Fellowship in Stereotactic Radiosurgery and Brachytherapy at the University of Pittsburgh Medical Center.
Experience:
- Currently serves as a Radiation Oncologist at the Regional Cancer Center-Lee Memorial Health System.
- Specializes in stereotactic radiosurgery, brachytherapy, and general radiation oncology.
Area of expertise
Lung Cancer
Paul M. Bloomston has run 3 trials for Lung Cancer. Some of their research focus areas include:
Pancreatic Cancer
Paul M. Bloomston has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
Regional Cancer Center-Lee Memorial Health System
Lee Memorial Health System
Clinical Trials Paul M. Bloomston is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting
4 awards
Phase 3
18 criteria
More about Paul M. Bloomston
Clinical Trial Related
8 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Paul M. Bloomston has experience with
- Paclitaxel
- Irinotecan Hydrochloride
- Carboplatin
- Nivolumab
- Ipilimumab
- Gemcitabine Hydrochloride
Breakdown of trials Paul M. Bloomston has run
Lung Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul M. Bloomston specialize in?
Paul M. Bloomston focuses on Lung Cancer and Pancreatic Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Paul M. Bloomston currently recruiting for clinical trials?
Yes, Paul M. Bloomston is currently recruiting for 5 clinical trials in Fort Myers Florida. If you're interested in participating, you should apply.
Are there any treatments that Paul M. Bloomston has studied deeply?
Yes, Paul M. Bloomston has studied treatments such as Paclitaxel, Irinotecan Hydrochloride, Carboplatin.
What is the best way to schedule an appointment with Paul M. Bloomston?
Apply for one of the trials that Paul M. Bloomston is conducting.
What is the office address of Paul M. Bloomston?
The office of Paul M. Bloomston is located at: Regional Cancer Center-Lee Memorial Health System, Fort Myers, Florida 33905 United States. This is the address for their practice at the Regional Cancer Center-Lee Memorial Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.